This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, provides interim agreement under FSS Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products. The contract has a ceiling value of $25,000.00 and a period of performance from February 1, 2025 to July 31, 2025. The prime contractor is Bridgebio Pharma, Inc., a for-profit organization. The contract does not utilize any set-asides and is a multiple award...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Vantive US Healthcare LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Federal Supply Schedule 65 IB. With a potential value of $25,000 and a period of performance through August 2024, this multiple-award schedule aims to ensure Veterans receive needed medical supplies and treatments. The...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Thea Pharma, Inc., is for the provision of pharmaceutical and hematology-related products under Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a period of performance through February 1, 2023. As a Federal Supply Schedule agreement, this contract provides a pre-negotiated catalog of products and services that can be ordered by federal agencies as needed. The specific...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Intrabio Inc., a small business, for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The contract has a ceiling value of $25,000 and a period of performance from February 1, 2025 to July 3, 2025. As an interim agreement, this contract provides the VA with access to Intrabio's catalog of medical products through the Federal Supply Schedule mechanism. The...
The Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Nextgen Pharmaceuticals LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. With a potential value of $400,000 and a period of performance through July 2028, the multiple award contract aims to meet the healthcare needs of veterans through the procurement of pharmaceuticals and...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Currax Pharmaceuticals LLC. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule program. The contract has a ceiling value of $25,000.00 and a period of performance through November 30, 2024. As a Federal Supply Schedule contract, this is a multiple award vehicle that...
The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Bioxcel Therapeutics, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through February 14, 2023. The contract is for an "Interim Agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products." This indicates the contract provides for the delivery of pharmaceutical and related...